The above suggest that FPS-ZM1 is a potent multimodal RAGE blocker that effectively controls the progression of Aβ-mediated neurodegeneration and, thus, may be used as a disease-modifying agent for AD. The gene discussed is AGER; the disease is Alzheimer disease.